TY - JOUR
T1 - Medical devices
T2 - from licensing to coverage. highlights from Argentina, Brazil, Colombia and Mexico
AU - Rey-Ares, Lucila
AU - Hernández-Vásquez, Akram
AU - Garay, Osvaldo Ulises
AU - Pichon Riviere, Andrés
AU - Garcia Marti, Sebastián
AU - Gilardino, Ramiro
AU - Cabra, Hermilio Arturo
AU - Augustovski, Federico
N1 - Publisher Copyright:
© 2016 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2016/11/1
Y1 - 2016/11/1
N2 - Objectives: To describe and compare the requirements for medical devices licensing and reimbursement in four Latin-American countries. Methods: We conducted a literature search in major databases, and generic Internet engines, and interviewed key informants. Results: We included all publications describing regulation and/or coverage and enriched them with key informant’s interviews. We found that licensing processes are similar. The decision-making process for coverage is not formally different than the one used for drugs. Although countries differ, Brazil, Colombia and Mexico have an explicit process informed by Health Technology Assessment. In general, coverage policies are defined for procedures and don´t specify device brand or model, and for that reason they may reimburse without explicit one by one device evaluation. Conclusions: The process for licensing and reimbursement is broadly similar but less stringent than that for drugs. It allows the adoption of medical devices without individual comprehensive assessment.
AB - Objectives: To describe and compare the requirements for medical devices licensing and reimbursement in four Latin-American countries. Methods: We conducted a literature search in major databases, and generic Internet engines, and interviewed key informants. Results: We included all publications describing regulation and/or coverage and enriched them with key informant’s interviews. We found that licensing processes are similar. The decision-making process for coverage is not formally different than the one used for drugs. Although countries differ, Brazil, Colombia and Mexico have an explicit process informed by Health Technology Assessment. In general, coverage policies are defined for procedures and don´t specify device brand or model, and for that reason they may reimburse without explicit one by one device evaluation. Conclusions: The process for licensing and reimbursement is broadly similar but less stringent than that for drugs. It allows the adoption of medical devices without individual comprehensive assessment.
KW - Latin America
KW - Medical devices
KW - coverage
KW - licensing
KW - reimbursement
UR - http://www.scopus.com/inward/record.url?scp=84992170319&partnerID=8YFLogxK
U2 - 10.1080/17434440.2016.1245611
DO - 10.1080/17434440.2016.1245611
M3 - Artículo
C2 - 27732123
AN - SCOPUS:84992170319
SN - 1743-4440
VL - 13
SP - 1053
EP - 1065
JO - Expert Review of Medical Devices
JF - Expert Review of Medical Devices
IS - 11
ER -